Biotech

AmberGen and Mass General License Two Novel Autoantigen Biomarkers for Autoimmune Liver Disease to INOVA Diagnostics

WATERTOWN, MA: ...

NuPathe to Report Fourth Quarter and Full Year 2011 Results and Hold Conference Call on Tuesday, March 20, 2012

CONSHOHOCKEN, PA: ...

Cornerstone Therapeutics Receives FDA Acceptance for CRTX 080 NDA for Treatment of Hyponatremia

CARY, NC: PDUFA Goal Date of October 29, 2012 ...

DSM and Agennix Sign New Contract for Commercial Manufacture of Talactoferrin

PLANEGG, GERMANY and MUNICH, GERMANY and PRINCETON, NJ and HOUSTON, TX: ...

Medivation, Inc. to Offer $175 Million Convertible Senior Notes Due 2017

SAN FRANCISCO, CA: ...

Threshold Pharmaceuticals' TH-302 to Be Featured at Symposium on Hypoxia in Cancer Hosted by the New York Academy of Sciences

SOUTH SAN FRANCISCO, CA: ...

Sunshine Heart Provides FAQ Regarding Transmutation of CDIs to Common Stock

SYDNEY, AUSTRALIA and EDEN PRAIRIE, MN: ...

Bradmer Announces Fourth Quarter and Fiscal Year 2011 Operational and Financial Results

TORONTO, ONTARIO: ...

Peregrine Reports Data From Phase II Front-Line Lung Cancer Trial

TUSTIN, CA: Promising Progression-Free Survival From Site Assessments; Overall Survival Endpoint From This Study Anticipated in Second Half of 2012 ...

Horizon Pharma Appoints Gino Santini to Board of Directors

DEERFIELD, IL: ...